Diabetes and COVID-19: Short- and Long-Term Consequences
Horm Metab Res 2022; 54: 503-509 DOI: 10.1055/a-1878-9566When the corona pandemic commenced more than two years ago, it was quickly
recognized that people with metabolic diseases show an augmented risk of severe
COVID-19 and an increased mortality compared to people without these
comorbidities. Furthermore, an infection with SARS-CoV-2 has been shown to lead
to an aggravation of metabolic diseases and in single cases to new-onset
metabolic disorders. In addition to the increased risk for people with diabetes
in the acute phase of COVID-19, this patient group also seems to be more often
affected by long-COVID and to experience more long-term consequences than people
without diabetes. The mechanisms behind these discrepancies between people with
and without diabetes in relation to COVID-19 are not completely understood yet
and will require further research and follow-up studies during the following
years. In the current review, we discuss why patients with diabetes have this
higher risk of developing severe COVID-19 symptoms not only in the acute phase
of the disease but also in relation to long-COVID, vaccine breakthrough
infections and re-infections. Furthermore, we discuss the effects of lockdown on
glycemic control. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of c...
Source: Hormone and Metabolic Research - Category: Endocrinology Authors: Steenblock, Charlotte Hassanein, Mohamed Khan, Emran G. Yaman, Mohamad Kamel, Margrit Barbir, Mahmoud Lorke, Dietrich E. Rock, John A. Everett, Dean Bejtullah, Saqipi Heimerer, Adrian Tahirukaj, Ermal Beqiri, Petrit Bornstein, Stefan R. Tags: Review Source Type: research
More News: Covid Vaccine | COVID-19 | Diabetes | Endocrinology | Hormones | Nutrition | Pandemics | SARS | Study | Vaccines